UPDATE: Stifel Nicolaus Raises Target on Stryker to $61

Stifel Nicolaus reiterates its Buy rating on Stryker

and raises its price target to $61 from $59 on increased visibility into 2012. Stifel Nicolaus says, "Adjusting for challenging 4Q2011 YoY growth comparisons, Stryker posted flat sequential revenue growth (+11% CC). Traction for new products and acquired businesses remain key drivers in driving momentum for Stryker. This is despite end-markets that continue to be challenged across all of Stryker's businesses in recon, MedSurg and spine; this also includes one-less selling day for recon in 4Q2011. Going into 2012, YoY growth comparisons only become easier. And, we contend management's 2012 guidance is modest as organic revenue growth is expected to be 2%-5% growth (vs. 4% organic revenue growth in 2011)." SYK closed at $52.94 a share on